{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:18:46Z","timestamp":1780582726452,"version":"3.54.1"},"reference-count":19,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Basic Clin Pharma"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0976-0105.183260","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T13:10:04Z","timestamp":1464700204000},"page":"65","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients"],"prefix":"10.4103","volume":"7","author":[{"given":"Tijana","family":"Kovacevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Milakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Spiric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedja","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0976-0105.183260-1","first-page":"10","volume-title":"Cost-effectiveness of therapeutic drug monitoring: A systematic review","author":"Touw","year":"2005","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0976-0105.183260-2","first-page":"1","volume-title":"Overview of therapeutic drug monitoring","author":"Kang","year":"2009","journal-title":"Korean J Intern Med"},{"key":"key-10.4103\/0976-0105.183260-3","first-page":"9","volume-title":"Pharmacokinetics made easy: Therapeutic drug monitoring","author":"Birkett","year":"1997","journal-title":"Aust Prescr"},{"key":"key-10.4103\/0976-0105.183260-4","first-page":"363","volume-title":", Nordstrom K.The challenge of in-hospital medication use: An opportunity for clinical pharmacology","author":"Atkinson","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0976-0105.183260-5","first-page":"3S","volume-title":"Therapeutic drug monitoring beyond 2000","author":"Shenfield","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.4103\/0976-0105.183260-6","unstructured":"Fitzpatrick R. Practical pharmacokinetics. In: Clinical Pharmacy and Therapeutics. 4 th ed. London, UK: Churchill Livingstone; 2007. p. 24-38."},{"key":"key-10.4103\/0976-0105.183260-7","unstructured":"Milena P. Farmakokinetika. 4 th ed. Belgrade, Serbia: School of Pharmacy, Belgrade University; 2012."},{"key":"key-10.4103\/0976-0105.183260-8","first-page":"306","volume-title":"Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization","author":"Crist","year":"1987","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0976-0105.183260-9","first-page":"9","volume-title":"Therapeutic drug monitoring","author":"Birkett","year":"1997","journal-title":"Aust Prescr"},{"key":"key-10.4103\/0976-0105.183260-10","first-page":"153","volume-title":"Why do therapeutic drug monitoring","author":"Thompson","year":"2004","journal-title":"Pharm J"},{"key":"key-10.4103\/0976-0105.183260-11","unstructured":"IBM Corp. IBM SPSS Statistics for Windows. Version 20.0. Armonk, NY: IBM Corp.; 2011."},{"key":"key-10.4103\/0976-0105.183260-12","first-page":"107","volume-title":"Optimizing aminoglycoside use","author":"Craig","year":"2011","journal-title":"Crit Care Clin"},{"key":"key-10.4103\/0976-0105.183260-13","first-page":"91","volume-title":"Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections","author":"Beaucaire","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0976-0105.183260-14","first-page":"64","volume-title":"An interventional study on intensive care unit drug therapy assessment in a rural district hospital in India","author":"Pichala","year":"2013","journal-title":"J Basic Clin Pharm"},{"key":"key-10.4103\/0976-0105.183260-15","first-page":"4 10 Suppl 2:S525","volume-title":"Optimizing antimicrobial therapy and emerging pathogens","author":"Nicolau","year":"1998","journal-title":"Am J Manag Care"},{"key":"key-10.4103\/0976-0105.183260-16","first-page":"292","volume-title":"Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling","author":"Nicolau","year":"2003","journal-title":"J Infect Chemother"},{"key":"key-10.4103\/0976-0105.183260-17","first-page":"R165","volume-title":"Therapeutic drug monitoring of amikacin in septic patients","author":"Duszynska","year":"2013","journal-title":"Crit Care"},{"key":"key-10.4103\/0976-0105.183260-18","first-page":"1","volume-title":"Therapeutic drug monitoring of gentamicin in patients with bronchopneumonia: Cost considerations and patient outcomes","author":"Ahmed","year":"2012","journal-title":"Eurasian J Med"},{"key":"key-10.4103\/0976-0105.183260-19","first-page":"605","volume-title":"A suggested approach to once-daily aminoglycoside dosing","author":"Begg","year":"1995","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal of Basic and Clinical Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T13:10:04Z","timestamp":1464700204000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbclinpharm.org\/text.asp?2016\/7\/3\/65\/183260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"alternative-id":["183260"],"URL":"https:\/\/doi.org\/10.4103\/0976-0105.183260","relation":{},"ISSN":["0976-0105"],"issn-type":[{"value":"0976-0105","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}